JPMorgan Adjusts Price Target on Fortive to $56 From $64

Fortive reported Q3 2026 revenue of $1.11B, up 7.8% YoY, with net income rising to $172.5M from $55M. Diluted EPS increased to $0.57 from $0.16. Core revenue growth was driven by pricing and volume, with IOS and AHS segments showing varied performance. The company completed the Ralliant separation in June 2025.

Fortive (FTV) reported Q3 EPS of $0.77, beating estimates by $0.06, with revenue at $1.11B, exceeding expectations. The company forecasts FY 2026 EPS of $3.10-$3.14, higher than the consensus of $3.01. FTV's stock is up 4.07% over the last 3 months and 22.41% over the last year.

Fortive reported Q3 2026 revenue of $1.11B, up 7.8% YoY, with adjusted EPS rising 13.2% to $0.77. The company raised its full-year adjusted EPS guidance to $3.10–$3.14. Core revenue growth was 7.2%, with Intelligent Operating Solutions up 9.1% and Advanced Healthcare Solutions up 3.1%. Fortive repurchased 5M shares for $300M during the quarter.

Fortive Corp (FTV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Fortive Reports Third Quarter 2026 Results • Q3 revenue growth accelerated to 7.8% year-over-year on a reported basis and 7.2% on a core basis • Delivered Q3 GAAP diluted EPS of $0.57, up 63% year-over-year, and adjusted diluted EPS of $0.77, up 13% year-over-year •

Fortive (FTV) reported Q3 2026 with 7% core growth, 10% adjusted EBITDA growth, and 13% adjusted EPS growth. The company raised FY26 adjusted EPS guidance to $3.10–$3.14.

Fortive (FTV) added Susan L. Main to its board and Audit Committee. The stock is trading at $54.69, down 11.13% in 30 days but up 12.5% over 1 year. Analysts suggest it may be 15% undervalued at a fair value of $64.36, citing operational excellence and disciplined capital allocation. However, its P/E ratio of 27.4x is higher than peers, indicating potential valuation risk.